COVID, FDA and vaccines
Digest more
The U.S. Food and Drug Administration (FDA) already declared that shortages of popular GLP-1 medications have ended, CNN reported. Those medications include semaglutide (Ozempic and Wegovy) and tirzepatide (Mounjaro and Zepbound).
A group of experts who advise the US Food and Drug Administration on its vaccine decisions voted unanimously Thursday to make a broad recommendation about which lineage of the coronavirus should be included in this year’s Covid-19 vaccines,
1don MSN
The vaccine eligibility change is a threat to the health of Americans, some experts say, adding that the FDA is not being forthcoming about its research.
2d
MedPage Today on MSNFDA Chief Defends Job Cuts, COVID Booster Policy at Senate HearingSeven weeks into his job as FDA commissioner, Marty Makary, MD, MPH, held his own answering a barrage of sometimes acrimonious questions from Senators about agency staffing cuts, limits on COVID boosters, and more.
Explore more
Government advisers are split on whether drugmakers should update their COVID-19 vaccines to better protect Americans this fall and winter.
The U.S. Food and Drug Administration is warning that certain half-shell oysters that are frozen and raw harvested in South Korea may be potentially contaminated with norovirus.
By Stephanie Brown HealthDay ReporterTHURSDAY, May 22, 2025 (HealthDay News) -- In February of this year, the U.S. Food and Drug Administration and U.S. Customs and Border Protection seized nearly 2 million units of unauthorized electronic cigarette products in Chicago.
The Food and Drug Administration will no longer approve COVID-19 vaccines for healthy people under 65 without rigorous trials.
The US Food and Drug Administration will now require Covid-19 vaccines from Pfizer/BioNTech and Moderna to use expanded warning labels with more information about the risk of a rare heart condition after vaccination.